PdRu bimetallic nanoalloys with improved photothermal effect for amplified ROS-mediated tumor therapy

An emerging strategy in cancer therapy involves inducing reactive oxygen species (ROS), specifically within tumors using nanozymes. However, existing nanozymes suffer from limitations such as low reactivity, poor biocompatibility, and limited targeting capabilities, hindering their therapeutic effic...

Full description

Saved in:
Bibliographic Details
Main Authors: Yujia Liang, Shufang Ning, Mekhrdod S. Kurboniyon, Khaiyom Rahmonov, Zhengmin Cai, Shirong Li, Jinling Mai, Xiaojing He, Lijuan Liu, Liping Tang, Litu Zhang, Chen Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2024.1523599/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561053941465088
author Yujia Liang
Shufang Ning
Mekhrdod S. Kurboniyon
Khaiyom Rahmonov
Zhengmin Cai
Shirong Li
Jinling Mai
Xiaojing He
Lijuan Liu
Liping Tang
Litu Zhang
Chen Wang
author_facet Yujia Liang
Shufang Ning
Mekhrdod S. Kurboniyon
Khaiyom Rahmonov
Zhengmin Cai
Shirong Li
Jinling Mai
Xiaojing He
Lijuan Liu
Liping Tang
Litu Zhang
Chen Wang
author_sort Yujia Liang
collection DOAJ
description An emerging strategy in cancer therapy involves inducing reactive oxygen species (ROS), specifically within tumors using nanozymes. However, existing nanozymes suffer from limitations such as low reactivity, poor biocompatibility, and limited targeting capabilities, hindering their therapeutic efficacy. In response, the PdRu@PEI bimetallic nanoalloys were constructed with well-catalytic activities and effective separation of charges, which can catalyze hydrogen peroxide (H2O2) to toxic hydroxyl radical (·OH) under near-infrared laser stimulation. Through facilitating electron transfer and enhancing active sites, the enhanced peroxidase-like (POD-like) enzymatic activity and glutathione (GSH) depletion abilities of nanozymes are boosted through a simple co-reduction process, leading to promising anti-tumor activity. The electron transfer between Pd and Ru of PdRu@PEI nanoalloys contributes to POD-like activity. Then, by oxidizing endogenous overexpressed GSH, enzymatic cycling prevents GSH from consuming ROS. Furthermore, the surface plasmon resonance effect of near-infrared laser on bimetallic nanoalloys ensures its photothermal performance and its local heating, further promoting POD-like activity. The integrated multi-modal therapeutic approach of PdRu@PEI has demonstrated significant anti-cancer effects in vivo studies. The nanozymes exhibit high catalytic efficiency and excellent biocompatibility, offering valuable insights for the development of nano-catalysts/enzymes for biomedical applications.
format Article
id doaj-art-a6817d0129594074bb83b4a9dde228f1
institution Kabale University
issn 2296-4185
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj-art-a6817d0129594074bb83b4a9dde228f12025-01-03T06:47:14ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852025-01-011210.3389/fbioe.2024.15235991523599PdRu bimetallic nanoalloys with improved photothermal effect for amplified ROS-mediated tumor therapyYujia Liang0Shufang Ning1Mekhrdod S. Kurboniyon2Khaiyom Rahmonov3Zhengmin Cai4Shirong Li5Jinling Mai6Xiaojing He7Lijuan Liu8Liping Tang9Litu Zhang10Chen Wang11Department of Experimental Research and Guangxi Cancer Molecular Medicine Engineering Research Center and Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, ChinaDepartment of Experimental Research and Guangxi Cancer Molecular Medicine Engineering Research Center and Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, ChinaNational Academy of Sciences of Tajikistan, Dushanbe, TajikistanNational Academy of Sciences of Tajikistan, Dushanbe, TajikistanDepartment of Experimental Research and Guangxi Cancer Molecular Medicine Engineering Research Center and Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, ChinaDepartment of Experimental Research and Guangxi Cancer Molecular Medicine Engineering Research Center and Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, ChinaDepartment of Experimental Research and Guangxi Cancer Molecular Medicine Engineering Research Center and Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, ChinaDepartment of Experimental Research and Guangxi Cancer Molecular Medicine Engineering Research Center and Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, ChinaDepartment of Experimental Research and Guangxi Cancer Molecular Medicine Engineering Research Center and Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, ChinaDepartment of Information, Library of Guangxi Medical University, Nanning, ChinaDepartment of Experimental Research and Guangxi Cancer Molecular Medicine Engineering Research Center and Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, ChinaDepartment of Experimental Research and Guangxi Cancer Molecular Medicine Engineering Research Center and Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, ChinaAn emerging strategy in cancer therapy involves inducing reactive oxygen species (ROS), specifically within tumors using nanozymes. However, existing nanozymes suffer from limitations such as low reactivity, poor biocompatibility, and limited targeting capabilities, hindering their therapeutic efficacy. In response, the PdRu@PEI bimetallic nanoalloys were constructed with well-catalytic activities and effective separation of charges, which can catalyze hydrogen peroxide (H2O2) to toxic hydroxyl radical (·OH) under near-infrared laser stimulation. Through facilitating electron transfer and enhancing active sites, the enhanced peroxidase-like (POD-like) enzymatic activity and glutathione (GSH) depletion abilities of nanozymes are boosted through a simple co-reduction process, leading to promising anti-tumor activity. The electron transfer between Pd and Ru of PdRu@PEI nanoalloys contributes to POD-like activity. Then, by oxidizing endogenous overexpressed GSH, enzymatic cycling prevents GSH from consuming ROS. Furthermore, the surface plasmon resonance effect of near-infrared laser on bimetallic nanoalloys ensures its photothermal performance and its local heating, further promoting POD-like activity. The integrated multi-modal therapeutic approach of PdRu@PEI has demonstrated significant anti-cancer effects in vivo studies. The nanozymes exhibit high catalytic efficiency and excellent biocompatibility, offering valuable insights for the development of nano-catalysts/enzymes for biomedical applications.https://www.frontiersin.org/articles/10.3389/fbioe.2024.1523599/fullnanoalloyreactive oxygen speciesglutathionephotothermal effecttumor therapy
spellingShingle Yujia Liang
Shufang Ning
Mekhrdod S. Kurboniyon
Khaiyom Rahmonov
Zhengmin Cai
Shirong Li
Jinling Mai
Xiaojing He
Lijuan Liu
Liping Tang
Litu Zhang
Chen Wang
PdRu bimetallic nanoalloys with improved photothermal effect for amplified ROS-mediated tumor therapy
Frontiers in Bioengineering and Biotechnology
nanoalloy
reactive oxygen species
glutathione
photothermal effect
tumor therapy
title PdRu bimetallic nanoalloys with improved photothermal effect for amplified ROS-mediated tumor therapy
title_full PdRu bimetallic nanoalloys with improved photothermal effect for amplified ROS-mediated tumor therapy
title_fullStr PdRu bimetallic nanoalloys with improved photothermal effect for amplified ROS-mediated tumor therapy
title_full_unstemmed PdRu bimetallic nanoalloys with improved photothermal effect for amplified ROS-mediated tumor therapy
title_short PdRu bimetallic nanoalloys with improved photothermal effect for amplified ROS-mediated tumor therapy
title_sort pdru bimetallic nanoalloys with improved photothermal effect for amplified ros mediated tumor therapy
topic nanoalloy
reactive oxygen species
glutathione
photothermal effect
tumor therapy
url https://www.frontiersin.org/articles/10.3389/fbioe.2024.1523599/full
work_keys_str_mv AT yujialiang pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT shufangning pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT mekhrdodskurboniyon pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT khaiyomrahmonov pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT zhengmincai pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT shirongli pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT jinlingmai pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT xiaojinghe pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT lijuanliu pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT lipingtang pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT lituzhang pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy
AT chenwang pdrubimetallicnanoalloyswithimprovedphotothermaleffectforamplifiedrosmediatedtumortherapy